General Announcement::Telix and FDA Agree Resubmission Pathway for Pixclara NDA

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
09-Sep-2025 06:44:52
Status
New
Announcement Sub Title
Telix and FDA Agree Resubmission Pathway for Pixclara NDA
Announcement Reference
SG250909OTHRVXWR
Submitted By (Co./ Ind. Name)
Marbill De Gracia
Designation
Secretariat
Effective Date and Time of the event
09/09/2025 00:00:00
Description (Please provide a detailed description of the event in the box below)
Announcement on ASX for TLX

Attachments

20250909 Pixclara Filing Update vFINAL For Lodging.pdf
Total size =200K